SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form SC 13G/A - Statement of acquisition of beneficial ownership by individuals: [Amend]
SEC Accession No. 0001104659-18-008445
Filing Date
2018-02-12
Accepted
2018-02-12 14:03:36
Documents
2
Group Members
BPIFRANCE INVESTISSEMENT S.A.S.BPIFRANCE S.A.CAISSE DES DEPOTS ET CONSIGNATIONSEPIC BPIFRANCEFONDS BIOTECHNOLOGIES INNOVANTES ET MALADIES RARES

Document Format Files

Seq Description Document Type Size
1 SC 13G/A a18-5586_1sc13ga.htm SC 13G/A 157178
2 EX-99.1 a18-5586_1ex99d1.htm EX-99.1 27548
  Complete submission text file 0001104659-18-008445.txt   186599
Mailing Address 1035 O'BRIEN DRIVE MENLO PARK CA 94025
Business Address 1035 O'BRIEN DRIVE MENLO PARK CA 94025 650-272-6269
Adverum Biotechnologies, Inc. (Subject) CIK: 0001501756 (see all company filings)

IRS No.: 205258327 | State of Incorp.: DE | Fiscal Year End: 1231
Type: SC 13G/A | Act: 34 | File No.: 005-88266 | Film No.: 18595639
SIC: 2836 Biological Products, (No Diagnostic Substances)

Mailing Address 27-31 AVENUE DU GENERAL LECLERC 94710 MAISONS ALFORT CEDEX FRANCE PARIS I0 75007
Business Address 27-31 AVENUE DU GENERAL LECLERC 94710 MAISONS ALFORT CEDEX FRANCE PARIS I0 75007 33153898789
Bpifrance Participations SA (Filed by) CIK: 0001581835 (see all company filings)

IRS No.: 000000000 | Fiscal Year End: 1231
Type: SC 13G/A